.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
.png)
New book from Joanna Stern highlights personal breast cancer journey
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
Radboudumc celebrates SPM's Nico Karssemeijer
As he departs Radboudumc as a professor, three leaders reflect on the legacy and impact of Nico Karssemeijer as a teacher and mentor.
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
ScreenPoint Medical announces $16 million investment from existing partners and research grants to fuel growth and build toward personalized care.
.png)
ScreenPoint Medical's founders honored
Nico Karssemeijer and Sir Michael Brady honored for their notable achievements and contributions to healthcare and the sciences.
.png)
ScreenPoint Medical and Ferrum Health partner to offer Transpara Breast AI through Ferrum’s AI Governance Suite
Ferrum Health will offer Transpara solutions through its Model Hub, helping radiologists increase breast cancer detection and improve their workflow
.png)
Our Top 5 in 2025
ScreenPoint Medical's top news, articles, blogs, and perspective from 2025.
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
ScreenPoint Medical has now made its Transpara® breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for Healthcare.